Invio
Cloud-based automation of clinical trial data quality monitoring.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
$100k | Seed | ||
| Total Funding | 000k | ||
Related Content
Invioinc operates ClinicalTrialsHub, an online platform dedicated to providing the latest information, resources, and opportunities related to clinical trials. The company serves medical professionals, researchers, and patients interested in participating in clinical research. Invioinc operates in the healthcare and medical research market, focusing on facilitating clinical trials for various diseases, including breast cancer, osteoarthritis, and liver cancer.
The business model revolves around offering a centralized hub where users can access detailed information about ongoing and upcoming clinical trials, read featured articles on medical conditions, and find opportunities to participate in cutting-edge research studies. Invioinc generates revenue through partnerships with research institutions, pharmaceutical companies, and healthcare providers who seek to promote their clinical trials and recruit participants.
By providing a trusted and comprehensive platform, Invioinc aims to advance medical research and improve patient outcomes through accurate information exchange and efficient trial participation.
Keywords: clinical trials, medical research, healthcare, breast cancer, osteoarthritis, liver cancer, patient recruitment, research studies, medical innovation, clinical research platform.